INM
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) has 5 SEC Form 4 filings (34 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 17, 2026.
The most active filer is 10% Owner Vivo Opportunity, LLC with 15 filings. Insiders have net bought $1.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Eric A. Adams Chem.
- Employees:13
- HQ:Vancouver, BC, CA
- IPO:2014-05-05
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$6.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 1,000 | $2K | Jul 17 | SEC ↗ | |
| 10% Owner | Purchase | 5,375 | $8K | Jul 17 | SEC ↗ | |
| 10% Owner | Purchase | 15,150 | $23K | Jul 17 | SEC ↗ | |
| 10% Owner | Purchase | 21 | $33 | Jul 17 | SEC ↗ | |
| 10% Owner | Purchase | 600 | $924 | Jul 2 | SEC ↗ | |
| 10% Owner | Purchase | 4,344 | $7K | Jul 2 | SEC ↗ | |
| 10% Owner | Purchase | 1,607 | $2K | Jul 2 | SEC ↗ | |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 56,210 | $88K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 34,000 | $57K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 17,796 | $28K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 16,336 | $25K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 22,848 | $35K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 7,783 | $12K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 6,743 | $11K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 55,011 | $86K | Jun 11 | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 32,500 | $49K | Jun 11 | SEC ↗ |
| 10% Owner | Purchase | 468,551 | $722K | May 21 | SEC ↗ |
Related companies
InMed Pharmaceuticals Inc. is in the Healthcare sector.